Navigation Links
Results of the BRIDGE trial reported at TCT 2011
Date:11/9/2011

SAN FRANCISCO, CA November 9, 2011 Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was effective at maintaining platelet inhibition in patients on thienopyridines who required bypass surgery. Trial results were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Thienopyridines are anti-platelet medications that work to prevent blood clotting and improve circulation. Though they are among the most widely prescribed medications, their use can be complicated by the unanticipated need for surgery. Despite increased risk of thrombosis, guidelines recommend discontinuing thienopyridines 5 7 days prior to surgery to minimize bleeding.

In the BRIDGE trial, researchers sought to determine whether the investigational drug cangrelor could be used as a "bridge" between discontinuing thienopyridines and surgery.

BRIDGE is a prospective, randomized double-blind, placebo-controlled, multicenter trial in 210 patients with acute coronary syndrome (ACS) or treated with a coronary stent on a thienopyridine awaiting coronary artery bypass grafting (CABG) to receive either cangrelor or placebo after an initial open-label, dose-finding phase. After thienopyridines were stopped, patients were administered cangrelor or a placebo for at least 48 hours, which was then discontinued 1 6 hours prior to surgery.

The primary efficacy endpoint of the trial was platelet reactivity (measured in P2Y12 Reaction Units [PRU]), assessed daily with the VerifyNowTM P2Y12 assay. The main safety endpoint was excessive CABG-related bleeding.

The dose of cangrelor determined in the open-label stage was 0.75 g/kg/min. In the randomized phase, a greater proportion of patients treated with cangrelor had low levels of platelet reactivity throughout the entire treatment period compared with placebo (primary en
'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. First results of Angiomax (bivalirudin) vs. heparin in transcatheter aortic valve interventions
2. Osteoarthritis results from inflammatory processes, not just wear and tear, Stanford study suggests
3. E-counselling shows dramatic results in lowering blood pressure
4. Less Frequent Mammograms May Lower False-Positive Results
5. Mayo Clinic wins grant to study ethics of sharing genetic test results with relatives
6. TGen/Virginia G. Piper Cancer Center publish results of new drug for pancreatic cancer patients
7. Virtual fly-through bronchoscopy yields real results
8. Mixed Results Seen With Off-Label Use of Antipsychotics
9. Company stock prices before public announcements of oncology trial results
10. Check Plastic Surgeons Credentials or Risk Tragic Results, Experts Warn
11. Parents anxiety about newborn screening results does not lead to increased health care use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... leader, Professor John Mathews from the University of Melbourne ... weighed against the undoubted benefits from CT scans in ... reported in the British Medical Journal today ... Oxford University, and the International Agency for Research on ... "CT scans were very useful in providing detailed three ...
(Date:5/22/2013)... percent of patients being treated for COPD at ... disease, researchers found after evaluating the patients with ... pulmonary disease. , "While there have been many ... not been a U.S.-based study that has quantified ... MSc, a second-year medical resident at Saint ...
(Date:5/22/2013)... The PreDiabetes Center of King ... Greater Philadelphia Tour de Cure, a premier cycling event that ... about stopping the spread of diabetes , a chronic ... The Tour de Cure will take place Saturday, June 1 ... Ambler, 30 minutes outside of Philadelphia, between the hours of ...
(Date:5/22/2013)... Detroit, Michigan (PRWEB) May 22, 2013 ... free service filters through local businesses and connects consumers ... seconds. Detroit’s residents have less time to handle personal ... their longer commutes to and from work. So, they ... searching for the right local available professional. , Now, ...
(Date:5/22/2013)... 22, 2013 CoCENTRIX, a leading ... Health and Human Services and community providers, announced ... (ADMH) selected the CoCENTRIX Coordinated Care Platform ... the Health Records and coordinate care within and ... , CoCENTRIX is transitioning the hospitals' official records ...
Breaking Medicine News(10 mins):Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Study finds COPD is over-diagnosed among uninsured patients 2Health News:Study finds COPD is over-diagnosed among uninsured patients 3Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3
... HealthDay Reporter , TUESDAY, May 15 (HealthDay News) -- ... works well in adolescents, new research indicates. Although ... "it is nice to have this officially shown in ... director of neurology at Maimonides Medical Center in New ...
... acid taken up to three times their recommended daily ... higher levels as some supplement manufacturers suggest, these three supplements ... a host of cancers. , "It,s not that these nutrients ... we need them in a certain balance," says Tim Byers, ...
... suggests that specific populations of tumor cells have different roles ... themselves and grow. In their report in the May ... tumor-propagating cell required for the growth of a pediatric muscle ... more-differentiated tumor cell must first travel to sites of new ...
... June,s Journal of Thoracic Oncology says molecular biomarkers ... an additional predictive technique for lung cancer screening. , ... of the positive CT screening results were false positive, scientists ... This research focused on a way to determine if the ...
... (SACRAMENTO, Calif.) A vaccine that targets cancer cells in ... breast cancer, significantly increased survival when tested in mice, a ... findings will be published today in the journal Clinical ... and the hormonal drug letrozole were more effective when given ...
... 15 (HealthDay News) -- Patient education and medication compliance contributed ... with life-threatening asthma admitted to the intensive care unit at ... review of 30 years of hospital data focused on patients ... They found that there were 227 patients admitted to the ...
Cached Medicine News:Health News:Two-Drug Combo Helps Teens With Migraines 2Health News:All cancer cells are not created equal 2Health News:All cancer cells are not created equal 3Health News:Cancer vaccine combination therapy shows survival benefit in breast cancer 2Health News:Inhaled Steroids Lead to Big Drop in Asthma Deaths at Texas Hospital: Study 2
(Date:5/22/2013)... 2013  Grifols, a global healthcare company based in ... a study demonstrating that a higher dose of PROLASTIN ... of the alpha 1 protein in patients with ... considered within the normal range for healthy individuals. AAT ... levels of the alpha 1 proteinase inhibitor (A1PI) ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... While many parents may think that allowing ... home under adult supervision keeps kids safe and leads ... there are serious negative consequences for both parents and ... The Treatment Research Institute (TRI) today announced the ... and caregivers to help inform them about one of ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 2Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 3Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 4Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 5Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 6Myths Debunked: Underage Drinking of Alcohol at Home Leads to Real Consequences for Both Parents and Teens 7
... June 28, 2011 The Mirixa Corporation and ... are pleased to announce that MirixaPro(SM), a Web-based ... patient care service delivery, will be deployed in ... agreement enabling CACDS to use a scalable, localized ...
... 2011 ,   The ... range of,new clinical data. The "Late-Breaking Clinical Trials" were ... SHPT study,(Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet,With ... June the,principal investigator of this study, Prof. Markus Ketteler,(Coburg, ...
Cached Medicine Technology:Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 2Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 3Update on IMPACT Study Results 2
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
... and ristocetin cofactor testing, couples a ... Windows-based software for unsurpassed testing flexibility. ... can be run on one Remote ... configure your analyzers to suite your ...
... Model 700 Whole Blood/Optical Lumi-Aggregometer available in ... new Aggregometer measures platelet function on patient ... or optical density in plasma with simultaneously ... The Model 700 Aggregometer also has the ...
Medicine Products: